Global HPV Testing Market Growth 2019-2024

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
HPV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.

According to this study, over the next five years the HPV Testing market will register a 8.4% CAGR in terms of revenue, the global market size will reach US$ 930 million by 2024, from US$ 580 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in HPV Testing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of HPV Testing market by product type, application, key manufacturers and key regions and countries.

This study considers the HPV Testing value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
HPV Testing
Follow-up HPV Testing
Co-testing
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cervical Cancer Screening
Vaginal Cancer Screening
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global HPV Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of HPV Testing market by identifying its various subsegments.
Focuses on the key global HPV Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the HPV Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of HPV Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.